DPHARM: Disruptive Innovations to Modernize Clinical Research

In this interview, Sean Connolly, Evinova, talks about what internal work sponsors need to do before picking a software to implement, the misalignments in a vendor partnership, and the work they are doing to help advance clinical trials. "You need to think systematically, and break down big problems into its component parts, because that allows you to deliver value iteratively as you work to achieve scale." Read the full interview here: https://lnkd.in/ebY428uT #DPHARM2025 #clinicaltrials #clinicalresearch

Join us on November 14th to hear from RealTime eClinical Solutions and ObjectiveHealth on how they’re integrating an advanced software infrastructure to enable clinical research as an extension of patient care. This webinar covers the impact of: - Leveraging process and performance transparency across an entire trial management organization to enhance staff accountability for completing outstanding tasks, meeting patient enrollment goals, and exceeding trial performance expectations - Optimizing system engagement to capture real-time data and automatically calculate turnaround or timing metrics across all study start-up milestones - Providing operational and executive leadership with end-to-end visibility at all times into trial performance Register here - https://lnkd.in/gFp2kiui #clinicalresearch #clinicaltrials #CRAACO

Wonderful article! Thanks Clinical Leader for these insights.

WEBINAR TOMORROW: Roadmap to CNS Trial Success This webinar will cover how integrated, unified solutions can address the inherent complexities of CNS trial endpoint assessment, ensuring rater consistency and improving both patient and site experiences. Medidata Solutions Learn more & register: https://lnkd.in/gZTkpixT

🌟 Exciting insights from the 2024 DPHARM conference! Ken Getz of Tufts Center for the Study of Drug Development shared vital strategies for measuring ROI in decentralized clinical trials (DCTs). Key takeaways include: • Broad ROI Understanding: ROI transcends mere finance; it’s a language that drives innovation and investment. • ENPV Modeling: Essential for assessing drug development’s financial value, comparing commercial performance against investment costs. • PACT Consortium: Aiming for improved data collection to optimize DCT implementation. Explore more about how these insights can transform clinical research: Read the full article #ClinicalTrials #DecentralizedTrials #ROI #DCTs Allyson Adams Valerie Bowling

🎯 Johnson & Johnson’s Commitment to Diversity in Clinical Trials 🌍 At The Janssen Pharmaceutical Companies of Johnson & Johnson, the pharmaceutical arm of Johnson & Johnson, inclusive clinical trials are not just a goal—they’re a mission. Their focus on embedding diversity into the clinical trial process is an industry-leading approach that could significantly improve health outcomes across underrepresented communities. In our recent coverage at #DPHARM, we explore how the team at Janssen, including senior leaders like Afia Afzal, is working to bring diverse populations into the fold and ensure trials truly reflect the real-world patient landscape. With innovative programs, partnerships, and technologies, Janssen is setting a benchmark in promoting inclusivity—driving change that benefits all patients, regardless of background. 📊💡 Read more on how Johnson & Johnson is taking diversity to new heights in clinical research. #ClinicalTrials #DiversityInTrials #Janssen #JohnsonAndJohnson #HealthEquity #ClinicalResearch #Innovation #PatientCentricity Allyson Adams

It's been a month since #DPHARM2024 and that time has allowed me to reflect on discussions and presentations. I was inspired by Captain Sully Sullenberger and Mike Rayburn to think about how we approach decisions on a daily basis, big or small. This is especially important as I work alongside my colleagues at CSL to save and improve the lives of patients around the world. Read more about my top five takeaways from these insightful presentations.

WEBINAR NEXT WEEK: Roadmap to CNS Trial Success This webinar will cover how integrated, unified solutions can address the inherent complexities of CNS trial endpoint assessment, ensuring rater consistency and improving both patient and site experiences. Medidata Solutions Learn more & register: https://lnkd.in/gZTkpixT

OneStudyTeam’s Chief Commercial Officer, Eben Scanlon, tells us about how he and his team are providing sponsors with pre-enrollment data, to help them better understand when and why interested potential participants don’t end up enrolling in trials, and helping to quantify and measure recruitment spend. Listen to the full podcast here: https://lnkd.in/gG3nCtdK #DPHARM #clinicaloperations #clinicalresearch #clinicaltrials

CEO Steve Herne, Unlearn.AI, discusses how pharma companies can leverage AI to accelerate trial timelines, reduce costs, and unlock new insights into patient outcomes that were previously impossible. "Unlike traditional approaches that rely on external cohort matching, digital twins forecast actual outcomes for individual participants." Read the full article here: https://lnkd.in/e6RAvQhb #AI #clinicalresearch #clinicaltrials #DPHARM